Manager/Sr Manager - Toxicology business development

Job Description Job Description 5 -15 years of experience in Preclinical CRO BD Business, Sales, Operational experience  and tox study pricing knowledge. Should have knowledge about Indian Pharmaceutical testing requirements so that she / he can pitch our services at right stage. Exposure to preclinical and experience in managing Indian pharma companies as account manager.   Self-driven, strong inclination to network and should be extrovert in nature Job requires frequent travel on monthly basis to client offices (minimum of 10 meetings at client office / month) Strongly believe in individual performance & Result oriented. Since Indian market we have sufficient connection, should have farming skills rather than hunting skills. To own target of Mn as individual performer. Good presentation and communication skills, both verbal and written.  Qualifications MSc / MBA Additional Information Skill Required Strong customer network, positive relationships, and knowledge of agreement execution Invivo or Toxicology business development role. Proficiency with CRM or customer relationship management tools. Excellent presentation and communication skills, ability to communicate concisely about product or service.  Experience in meeting the month-on-month sales targets. Behavioural Competencies. Company Description Eurofins Advinus is a premier preclinical and early development CRO offering drug discovery, preclinical and development stage contract research services in the areas of discovery services, regulatory Toxicology (Safety Assessment), DMPK, Analytical R&D Services and API CDMO. Eurofins Advinus manufactures drug substances to support Toxicology and early clinical studies. With over 30 years of GLP compliance and certification, Eurofins Advinus serves diverse industries such as Biotech, Pharmaceutical, Biological, Agrochemical, Nutraceutical and Cosmetic. Eurofins Advinus is the only contract research organization (CRO) in India to have developed data in support of 90+ end-to-end IND enabling packages to be submitted to global regulators such as USFDA, EMA, MHRA, Health Canada and others.